Slide 11 NIST, September 25 2007 Biotechnology and Public Health: Scenarios to 2030 Anthony Arundel Organisation for Economic Cooperation and Development International Futures…

1.TOYOPEARL AF-rProtein A HC-650F Ultra-High Capacity Protein A ResinTosoh Bioscience GmbH2. Antibody Biotherapeutics IncreasingSource: BIOPHARMA: Biopharmaceutical Products…

PowerPoint Presentation CONCEPT OF BIOSIMILARS KIRANKAUR OBEROI, FIRST YEAR M.PHARM(QUALITY ASSURANCE) OVERVIEW Introduction Definition Biologics vs. small molecules Science…

1.   TRANSGENIC PLANTS AS SOLE SOURCE FOR BIOPHARMACEUTICALS BY MUKUND JOSHI (MSc Medical Biochemistry) 2. • Subhash Goyal (Professor)2 ,K.S. Sodhi (Professor)1 , Jasbir…

Pioneer Institute of Professional Studies, Indore A RESEARCH PAPER ON Growth of Indian Pharmaceutical Industry PIONEER (Since 1996) Submitted to Submitted By Prof. Dr. V…

Slide 1 Layered Manufacturing Technologies u Powder Solidification l 3D Printing (3DP) l Selective Laser Sintering (SLS) u Additive With Sacrificial Supports l Stereolithography…

Slide 1 Emerging Trends in Plasma-free Manufacturing of Recombinant Protein Therapeutics Expressed in Mammalian Cells Yiben Wang 11/16/11 Leopold Grillberger, Thomas R. Kreil,…

Slide 1 EU - JAPAN FTA Perspectives from the pharmaceutical industry EESC – Hearing on EU - Japan FTA Brussels, 15 January 2014 1 Slide 2 Pharmaceuticals: trading with…

Corporate Presentation Financial Results H1 FY 2006 Disclaimer Consolidated revenues grew by 4% over H1 â FY 05. Operating profits fell by 8% over H1 â FY 05. Profit after…

MAY 1-3, 2012 JAVITS CENTER l NEW YORK, NY BRINGING TOGETHER KEY PHARMA AND BIOTECH PROFESSIONALS WITH SUPPLIERS TO CREATE INNOVATIVE SOLUTIONS. INSIGHT ⢠INNOVATION ⢅